Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Inmune Bio, Inc. from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Inmune Bio, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q2 2019 to Q3 2025.
  • Inmune Bio, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2025 was $405K.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $405K 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $91K -$107K -54% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $51K -$147K -74.2% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $198K +$5K +2.59% 31 Dec 2024 10-K 27 Mar 2025
Q2 2024 $198K 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $198K 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $193K 31 Dec 2023 10-K 28 Mar 2024
Q4 2021 $198K 31 Dec 2021 10-Q 31 Oct 2024
Q3 2019 $50K 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $50K 30 Jun 2019 10-Q 09 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.